| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AFRC & MRC Neuropathogenesis Unit, West Mains Road, Edinburgh EH9 3JF, U.K.
A single intraperitoneal injection of 250 µg dextran sulphate 500 (DS500) reduced the susceptibility of mice to scrapie given by the same route. A lower dose (25 µg) was less effective but still produced significant incubation period lengthening, while a high dose (2.5 mg) further increased the degree of prolongation. This reduced susceptibility occurred with DS500 administered up to at least 4 weeks prior to intraperitoneal scrapie inoculation and up to at least 2 weeks after scrapie inoculation. A reduced average effect, but more variable between mice, was obtained with DS500 given 1 month or 2 months after scrapie. The effective scrapie titre was reduced by 90% when DS500 was injected either 72 h before or 7 h after ME7 scrapie. Using a relatively lower but normally still fatal dose of the 22A strain of scrapie approximately 50% of the treated mice survived. The effective 90% loss of titre was consistent with either of these strains of scrapie in 11 different inbred strains of mice (BALB/c, BSC, BRVR, C3H, C57BL, IM, LM, MM, RIII, VL and VM). No significant increase in the prolongation effect was obtained using multiple DS500 doses in two different time combinations. DS500 causes long-term interference in both the early processing and the replication of scrapie agent, unlike those immunomodulators which increase susceptibility.
Keywords: scrapie, incubation period, dextran sulphate
Received 4 September 1985;
accepted 25 November 1985.
This article has been cited by other articles:
|
|
 |
|
  C.-H. Song, H. Furuoka, C.-L. Kim, M. Ogino, A. Suzuki, R. Hasebe, and M. Horiuchi Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice J. Gen. Virol., June 1, 2008; 89(6): 1533 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Colby, Q. Zhang, S. Wang, D. Groth, G. Legname, D. Riesner, and S. B. Prusiner Prion detection by an amyloid seeding assay PNAS, December 26, 2007; 104(52): 20914 - 20919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Trevitt and J. Collinge A systematic review of prion therapeutics in experimental models Brain, September 1, 2006; 129(9): 2241 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kocisko, A. Vaillant, K. S. Lee, K. M. Arnold, N. Bertholet, R. E. Race, E. A. Olsen, J.-M. Juteau, and B. Caughey Potent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides Antimicrob. Agents Chemother., March 1, 2006; 50(3): 1034 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Barret, L. Forestier, J.-P. Deslys, R. Julien, and P. F. Gallet Glycosylation-related Gene Expression in Prion Diseases: PrPSc ACCUMULATION IN SCRAPIE INFECTED GT1 CELLS DEPENDS ON {beta}-1,4-LINKED GalNAc-4-SO4 HYPOSULFATION J. Biol. Chem., March 18, 2005; 280(11): 10516 - 10523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Kocisko, J. D. Morrey, R. E. Race, J. Chen, and B. Caughey Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice J. Gen. Virol., August 1, 2004; 85(8): 2479 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Adjou, S. Simoneau, N. Sales, F. Lamoury, D. Dormont, D. Papy-Garcia, D. Barritault, J.-P. Deslys, and C. I. Lasmezas A novel generation of heparan sulfate mimetics for the treatment of prion diseases J. Gen. Virol., September 1, 2003; 84(9): 2595 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Barret, F. Tagliavini, G. Forloni, C. Bate, M. Salmona, L. Colombo, A. De Luigi, L. Limido, S. Suardi, G. Rossi, et al. Evaluation of Quinacrine Treatment for Prion Diseases J. Virol., August 1, 2003; 77(15): 8462 - 8469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Caughey, L. D. Raymond, G. J. Raymond, L. Maxson, J. Silveira, and G. S. Baron Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin J. Virol., May 1, 2003; 77(9): 5499 - 5502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Forloni, S. Iussich, T. Awan, L. Colombo, N. Angeretti, L. Girola, I. Bertani, G. Poli, M. Caramelli, M. Grazia Bruzzone, et al. Tetracyclines affect prion infectivity PNAS, August 6, 2002; 99(16): 10849 - 10854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Warner, C. Hundt, S. Weiss, and J. E. Turnbull Identification of the Heparan Sulfate Binding Sites in the Cellular Prion Protein J. Biol. Chem., May 17, 2002; 277(21): 18421 - 18430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vorberg, K. Chan, and S. A. Priola Deletion of {beta}-Strand and {alpha}-Helix Secondary Structure in Normal Prion Protein Inhibits Formation of Its Protease-Resistant Isoform J. Virol., November 1, 2001; 75(21): 10024 - 10032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Mabbott and M. E. Bruce The immunobiology of TSE diseases J. Gen. Virol., October 1, 2001; 82(10): 2307 - 2318. [Full Text] [PDF]
|
|
|
|
|
|
S. Supattapone, H. Wille, L. Uyechi, J. Safar, P. Tremblay, F. C. Szoka, F. E. Cohen, S. B. Prusiner, and M. R. Scott Branched Polyamines Cure Prion-Infected Neuroblastoma Cells J. Virol., April 1, 2001; 75(7): 3453 - 3461. [Abstract] [Full Text]
|
|
|
|
|
|
V. Beringue, K. T. Adjou, F. Lamoury, T. Maignien, J.-P. Deslys, R. Race, and D. Dormont Opposite Effects of Dextran Sulfate 500, the Polyene Antibiotic MS-8209, and Congo Red on Accumulation of the Protease-Resistant Isoform of PrP in the Spleens of Mice Inoculated Intraperitoneally with the Scrapie Agent J. Virol., June 15, 2000; 74(12): 5432 - 5440. [Abstract] [Full Text]
|
|
|
|
|
|
K. Doh-ura, T. Iwaki, and B. Caughey Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation J. Virol., May 15, 2000; 74(10): 4894 - 4897. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Mabbott, A. Williams, C. F. Farquhar, M. Pasparakis, G. Kollias, and M. E. Bruce Tumor Necrosis Factor Alpha-Deficient, but Not Interleukin-6-Deficient, Mice Resist Peripheral Infection with Scrapie J. Virol., April 1, 2000; 74(7): 3338 - 3344. [Abstract] [Full Text]
|
|
|
|
|
|
R. Demaimay, R. Race, and B. Chesebro Effectiveness of Polyene Antibiotics in Treatment of Transmissible Spongiform Encephalopathy in Transgenic Mice Expressing Syrian Hamster PrP Only in Neurons J. Virol., April 1, 1999; 73(4): 3511 - 3513. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. Caughey, L. D. Raymond, M. Horiuchi, and B. Caughey Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines PNAS, October 13, 1998; 95(21): 12117 - 12122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tagliavini, R. A. McArthur, B. Canciani, G. Giaccone, M. Porro, M. Bugiani, P. M. Lievens, O. Bugiani, E. Peri, P. Dall'Ara, et al. Effectiveness of Anthracycline Against Experimental Prion Disease in Syrian Hamsters Science, May 16, 1997; 276(5315): 1119 - 1121. [Abstract] [Full Text]
|
|
|
|
|
|
S.-L. Shyng, S. Lehmann, K. L. Moulder, and D. A. Harris Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrP^C, in Cultured Cells J. Biol. Chem., December 15, 1995; 270(50): 30221 - 30229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Shaked, Z. Meiner, I. Avraham, A. Taraboulos, and R. Gabizon Reconstitution of Prion Infectivity from Solubilized Protease-resistant PrP and Nonprotein Components of Prion Rods J. Biol. Chem., April 20, 2001; 276(17): 14324 - 14328. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
